Busulfan, Melphalan, and Bortezomib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Busulfan, Melphalan, and Bortezomib, covering 2020-08-20 to 2020-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]